about
Reversal agents for NOACs: Connecting the dotsAtrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment optionsMinimizing bleeding risk in patients receiving direct oral anticoagulants for stroke preventionIntracerebral haemorrhage: an often neglected medical emergencyBenefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis.Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleedingActivated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathyManagement of anticoagulant-related intracranial hemorrhage: an evidence-based review.A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal.Prothrombin complex concentrates: an update.Hereditary combined deficiency of the vitamin K-dependent clotting factors.Epidemiological characteristics of 778 patients who underwent surgical drainage of chronic subdural hematomas in Brasília, Brazil.Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review.An audit of the role of vitamin K in the reversal of International Normalised Ratio (INR) in patients undergoing surgery for hip fracture.Management of warfarin anticoagulation in patients with fractured neck of femur.Reversal of warfarin-induced hemorrhage in the emergency department.Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.Comparison between Prothrombin Complex Concentrate (PCC) and Fresh Frozen Plasma (FFP) for the Urgent Reversal of Warfarin in Patients with Mechanical Heart Valves in a Tertiary Care Cardiac CenterA review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients"Early Trigger" Intravenous Vitamin K: Optimizing Target-Driven Care in Warfarinised Patients With Hip FractureAppraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.Pharmacologic reversal of warfarin-associated coagulopathy in geriatric patients with hip fractures: a retrospective study of thromboembolic events, postoperative complications, and time to surgery.Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants.Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice.Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more.An evidence-based warfarin management protocol reduces surgical delay in hip fracture patients.Treatment and monitoring of coagulation abnormalities in children undergoing heart surgery.Urgent reversal of vitamin K antagonist therapy.Controversies of anticoagulation reversal in life-threatening bleeds.The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy.Oral anticoagulant-associated intracerebral hemorrhage.The surgical management of chronic subdural hematoma.Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding.Emergency neurological life support: intracerebral hemorrhage.Current state of knowledge on oral anticoagulant reversal using procoagulant factors.Antivitamins for Medicinal Applications.Emergency Neurological Life Support: Intracerebral Hemorrhage.Acute Warfarin Toxicity as Initial Manifestation of Metastatic Liver Disease.Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation.
P2860
Q26740248-4A0E1BDF-2FBF-4B0C-9C89-45BB9FF1420EQ26799571-DB64022F-97B9-444B-98CF-460D7F8C0140Q28069809-8AB426C2-982B-4A33-B058-46B82489AA0AQ28212587-5817684F-9775-41B2-BE6E-68B4E9F2ACD1Q30234372-A145094B-9860-4C59-8604-B27E4B5AFABAQ33612839-1703E3DD-DFB2-41DC-AB01-4556BF401DA3Q33735132-A3D28127-2973-4161-8847-5335A48314F4Q33750215-77375083-1E0B-4B52-B6A8-309CF02E37E3Q33754796-C5533F55-7C70-4FEB-8382-1C51B9BED542Q34003474-45DD346C-FAEE-4DFE-9CAE-DF4D859ECBFDQ34035983-1136F576-DEBA-4E82-A257-C3BF3A31D00AQ34604565-34B44104-7A64-4EFC-8678-C05A87A9C945Q35121230-D0B1075C-E32E-4936-A459-A5C67D15B8DFQ35240241-4C813D6E-71B1-4800-BC99-B7E2499D7C62Q35368699-CFC8F998-1E60-45CA-BE0A-C198959D363DQ35608280-D9F25FF4-9AB8-4F19-8E52-538C7F417E44Q35711431-4C9F3445-40D6-4234-A457-4B33A07F0023Q35897909-103FF741-E1A4-4130-8595-1177AEF1604AQ36146339-D3C8C1CB-580C-48F8-8D38-3713BD4C9567Q36285795-AB24937F-3B1C-4ACD-8BC0-2F6E31F0EF3EQ36624112-85AB5758-8243-4B84-83FA-B580A89CFD41Q36684043-27B3086E-FAC8-4D8A-9524-3DAB552302C5Q36874702-53D48E72-B476-4405-8A52-3E97582047AAQ36928194-97B06FA0-A8B8-4CA4-8DCF-1ED67C6970E1Q37210021-3808D5DB-BB4E-43C7-B3CD-4B6F31D18CC1Q37233377-9FB45B39-B6ED-4796-BFF4-1CB4BC094C16Q37628400-D76A71F6-F6EB-4D6F-AAAB-C90C77939C28Q37813802-9A3F4FE8-154E-464A-9EA6-BAA00F4AF60CQ37854814-760AD726-1CC3-42B9-A97E-5CE03A691839Q37867279-EFE42560-1C35-4007-8145-4EBF34F3FE7AQ37873969-6BCD5C58-3F6C-4D3C-8FDB-021F9D2C9881Q37900185-9EE42203-B5C2-4E73-96BD-B2EBFC5C8F32Q37930462-50FC22BA-1EA9-4290-9F70-3DE9BCA729D4Q37997442-E526D116-CFBB-4D92-92E9-4009470E9A41Q38042353-57FC6C54-1590-48FD-9FB9-02017A7E283AQ38108527-7DC9CB70-3415-4858-B47D-4BE7BE8B732CQ38503308-B6FF37B4-161B-4F64-9C1D-366C1C9CCA9DQ38599754-01F41039-642C-4753-86B2-4CC770432C81Q39024448-B22D2311-2C6D-447B-924B-864F59FDBFB7Q39129273-1E2D0024-13E2-4CFC-B79C-547644ABC0E5
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Warfarin reversal
@ast
Warfarin reversal
@en
Warfarin reversal
@nl
type
label
Warfarin reversal
@ast
Warfarin reversal
@en
Warfarin reversal
@nl
prefLabel
Warfarin reversal
@ast
Warfarin reversal
@en
Warfarin reversal
@nl
P2860
P3181
P356
P1476
Warfarin reversal
@en
P2093
J P Hanley
P2860
P304
P3181
P356
10.1136/JCP.2003.008904
P407
P577
2004-11-01T00:00:00Z